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Abstract
Background: Mannose receptor (MR) is a member of the C-type lectin receptor family involved in pathogen
molecular-pattern recognition and thought to be critical in shaping host immune response. The aim of this study
was to investigate potential associations of genetic variants in the MRC1 gene with sarcoidosis.
Methods: Nine single nucleotide polymorphisms (SNPs), encompassing the MRC1 gene, were genotyped in a total
of 605 Japanese consisting of 181 sarcoidosis patients and 424 healthy controls.
Results: Suggestive evidence of association between rs691005 SNP and risk of sarcoidosis was observed
independent of sex and age in a recessive model (P = 0.001).
Conclusions: These results suggest that MRC1 is an important candidate gene for sarcoidosis. This is the first study
to imply that genetic variants in MRC1, a major member of the C-type lectin, contribute to the development of
sarcoidosis.
Background
Sarcoidosis is a multi-organ inflammatory disease with
exaggerated cellular immune activity that leads to for-
mation of non-caseating granulomas in the affected
organs. Although the causes of sarcoidosis remain
unclear, several lines of evidence support the idea that
sarcoidosis results from exposure of genetically suscepti-
ble individuals to unknown environmental triggers [1-9].
Amomg this evidence, environmental pathogens such as
Mycobacterium and Propionibacterium species have
been suggested to play roles in the pathogenesis of sar-
coidosis [7-9]. Recent insights into the complex
mechanisms underlying human innate immunity suggest
that genetic variability in the genes encoding immune
system components plays a role in the development of
chronic inflammatory diseases. In particular, the associa-
tion between sarcoidosis and genetic variants of several
pattern recognition receptors (PRRs), such as Toll-like
receptors (TLRs), have been extensively analyzed
[10-12]. Although TLRs are an important system for
microbial sensing, they are not the only PRRs with this
function. At the cell-surface, C-type lectin-like mole-
cules, such as the mannose receptor and the b-glucan
receptors, also participate in the binding and uptake of
microbial components [13,14]. Components of bacteria
and viruses that gain entry into the cytoplasm are recog-
nized by cytosolic receptors, through which they induce
cytokine production and cell activation [15,16]. Recent
studies have shown the genetic association between sar-
coidosis and non-TLRs [11,17]. Mannose receptor (MR)
is a member of the pattern-recognition C-type lectin
receptor (CLR) family, which plays an important role in
innate immunity. MR is predominantly present on
macrophages and dendritic cells and recognizes glycan
structures containing mannose, fucose and N-acetylglu-
cosamine, which are commonly found on the cell walls
of pathogenic micro-organisms such as mycobacteria,
fungus, parasites and yeast [18]. We therefore speculated
that the MRC1 gene may be an excellent candidate for
susceptibility to sarcoidosis, and tested for associations
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sarcoidosis in our Japanese case-control analysis.
Methods
Subjects
We enrolled unrelated subjects in this case-control
study to search for susceptibility genes to sarcoidosis. A
total of 181 Japanese subjects with sarcoidosis were
recruited from the pulmonary clinic of the First Depart-
ment of Medicine at Hokkaido University Hospital.
Diagnosis of sarcoidosis in each patient was based on
compatible clinical findings, histological demonstration
of noncaseating epithelioid cell granuloma, and exclu-
sion of other diseases capable of producing a similar his-
tological or clinical picture, as recommended by the
American Thoracic Society (ATS)/European Respiratory
Society (ERS)/World Association of Sarcoidosis and
Other Granulomatous Disorders (WASOG) statement.
A total of 424 healthy controls, comprising individuals
with no history of asthma or any other chronic pulmon-
ary diseases, were recruited from individuals visiting the
clinic for annual routine physical examinations and stu-
dents at the School of Medicine at Hokkaido University.
All subjects were unrelated and of Japanese descent.
The medical ethics committee of Hokkaido University
Graduate School of Medicine approved this study.
SNP Selection and Genotyping
Initially, we selected and genotyped seven SNPs in the
MRC1 gene [12555A/G (rs2477637), 13789G/A
(rs2253120), 17023A/C (rs2477631), 24351A/T
(rs2477664), 31598A/G (rs692527), 40240G/A (rs1926736)
and 111380T/C (rs691005)] based on our previous report
[19]. As rs691005 showed a significant association, but
major haplotyopes with strong linkage disequilibrium (LD)
are not constructed by rs691005 using these 7 SNPs as
described below (Figure 1), we genotyped two additional
SNPs [11041G/A (rs554995) and 11065G/A (rs554313)]
which are located close to rs691005. Additional LD struc-
ture using these 3 SNPs was shown in Figure 2. Alleles
were identified using an assay combining kinetic (real-
time quantitative) PCR with allele-specific amplification,
as described elsewhere [19]. Real-time PCR was performed
using SYBER Green I Master Mix (Applied Biosystems,
Foster City, CA, USA) and an ABI PRISM TM 7700
Sequence Detection System (Applied Biosystems). Primers
for allele specific PCR are shown in Table 1. rs554995 and
rs554313 were genotyped using the TaqMan system
(Applied Biosystems).
Statistical Analysis
Each of the SNPs in the MRC1 gene was tested for
deviation from Hardy-Weinberg equilibrium using a c
2
test. Both genotypic and allelic association among
subjects with sarcoidosis and healthy controls were sta-
tistically compared using the logistic regression analysis
adjusting for sex and age. The relative risk was esti-
mated as odds ratios (OR) with 95% confidence intervals
(95%CI). For LD mapping, pair-wise LD between poly-
morphisms in MRC1 was evaluated using Haploview
software version 4.2 [20]. For haplotype analyses, we
used the haplo.score program, which calculates simula-
tion P values for each haplotype and further adjusts for
covariates. Haplotypes with frequency below 5% were
excluded from haplotype analysis. These statistical ana-
lyses were performed using a program R version 2.11.1
(http://www.R-project.org/) [21]. P values were adjusted
using the Bonferroni correction for 10 tests. Levels of
significance for all statistical analyses were set to P <
0.005.
Results
Demographic characteristics of the 424 healthy controls
and 181 subjects with sarcoidosis from this population
are listed in Table 2. Median age was significantly higher
for subjects with sarcoidosis than for healthy control
subjects (P < 0.05). The sarcoidosis group included sig-
nificantly more females than the control group (P <
0.05). Pair-wise LD values for 7 SNPs are shown in Fig-
ure 1. No significant deviation from the Hardy-Wein-
berg equilibrium was observed in healthy control
subjects (P > 0.05). Genotype and allele frequencies and
Figure 1 Linkage disequilibrium structure (LD) of MRC1 gene
across the 98.8 kb in Japanese (n = 605). Black squares represent
high pairwise linkage disequilibrium, coloring down to white
squares of low pairwise linkage disequilibrium. The numbers in the
individual squares are D’ multiplied by 100.
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Table 3. When we performed logistic repression analysis
using a recessive model adjusted for age and gender, 3
SNPs tended to be associated with sarcoidosis
(rs2477637, OR 1.76, 95%CI, 1.09-2.84, P =0 . 0 2 ;
rs692527, OR 1.58, 95%CI 1.02-2.46, P =0 . 0 4 2 ;a n d
rs691005, OR 2.53, 95%CI 1.47-4.37, P =0 . 0 0 1 ;T a b l e
4). Additional association was observed for SNP
rs2253120 (OR 1.62, 95%CI 1.12-2.36, P =0 . 0 1 1 ) ,w h e n
analysis was performed under a dominant model. The
rs691005 SNP remained statistically significant after
Bonferroni correction. The linkage disequilibrium map
constructed from 7 SNPs is shown in Figure 1, as mea-
sured by D prime and we identified two haplotype
blocks. Haplotype block 1 comprised two SNPs
(rs2477631 and rs2477664), and haplotype block 2 com-
prised two SNPs (rs692527 and rs1926736). However,
significant association was not found in haplotype analy-
sis (Table 5).
Based on LD structure and significant association of
rs691005 for initial analysis, we further genotyped two
additional SNPs (rs554995 and rs554313) close to
rs691005. Unfortunately, these two SNPs did not show
significant associations (Tables 3 and 4). Although three
SNPs (rs554995, rs554313 and rs691005) showed strong
LD, significant associations were not found in haplotype
analysis (Table 5).
Discussion
In the present study we demonstrated the association
between MRC1 polymorphisms and risk of sarcoidosis in
Japanese population. In support of this, the association of
Figure 2 Linkage disequilibrium structure (LD) of 3 SNPs
(rs544995, rs544313 and rs691005) in MRC1 gene. Black squares
represent high pairwise linkage disequilib. The numbers in the
individual squares are D’ multiplied by 100.
Table 1 Primers for allele specific PCR
Locus* Primer sequence
12555 Forward 5’ ACTCAGTTACTTTCATTTGTTTATTCCTTAAC 3’
Reverse for A 5’ CCTTTAATTAAATCAAAATTGAGTTCAT 3’
Reverse for G 5’ CCTTTAATTAAATCAAAATTGAGTTCAC 3’
13789 Forward 5’ GAATCTCAGATTATGAGTGTTGCATTT 3’
Reverse for A 5’ CATAGAGAGTGATAGCAACCCAGTCT 3’
Reverse for G 5’ CATAGAGAGTGATAGCAACCCAGTCC 3’
17023 Forward for A 5’ GGGATTGCAAGCGTGAGACA 3’
Forward for C 5’ GGGATTGCAAGCGTGAGACC 3’
Reverse 5’ TTTGCAGATTCTACGACTTGAAAAAG 3’
24351 Forward for A 5’ GAGCTCCTGAGCATCACAGAGATA 3’
Forward for T 5’ GAGCTCCTGAGCATCACAGAGATT 3’
Reverse for A 5’ ACTACCTGTCAGGTATGTTTGCTCAT 3’
Reverse for T 5’ CTTACCTGTCAGGTATGTTTGCTCAT 3’
31598 Forward for A 5’ CAATAAAGGTCTCTGTTTAAAGTTTCAA 3’
Forward for G 5’ CAATAAAGGTCTCTGTTTAAAGTTTCAG 3’
Reverse for A 5’ CAACACATCAGGGATACTCTGAGAAT 3’
Reverse for G 5’ GTACCCAACACATCAGGGATACTCT 3’
40240 Forward 5’ AGGGATGCTCTGACCACCTG 3’
Reverse for A 5’ GTGTGGATACTTGCGAGGTCTCT 3’
Reverse for G 5’ TGTGGATACTTGGGAGGTCTCC 3’
111380 Forward for C 5’ TCTCTTTGGTACAACATAGTAAATCTCACC 3’
Forward for T 5’ TCTCTTTTTGGTACAACATAGTAAATCTCACT 3’
Reverse for C 5’ TTACCAACTGTTTTCCCATAATTGTG 3’
Reverse for T 5’ CCAACTGTTTTCCCATAATTGTGAG 3’
* Nucleotide numbering starts from the first nucleotide of the transcription
start site.
Table 2 Characteristics of 605 Japanese subjects
Japanese population Control
(n = 424)
Sarcoidosis
(n = 181)
P
value
Male (%)* 65.3 30.9 <0.05
Age (median, range)
† 38, 18-72 45, 10-78 <0.05
Stage (0/I/II/III/IV) - 21/90/59/11/0
Occular lesion (%) - 54.7
Cutaneous lesion (%) - 17.7
Cardiac lesion (%) - 7.2
Data are presented as median (interquartile range). * c
2 test † Mann-Whiteney
U test.
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Page 3 of 6one SNP (rs691005) was confirmed considering for mul-
tiple testing and Bonferroni correction, suggesting MRC1
gene as a plausible candidate gene for development of
sarcoidosis. Of interest, recent genome-wide association
analyses have shown that 10p12, where MRC1 is situated,
is a susceptibility locus for the development of sarcoido-
sis [22]. Thus, findings of the current study suggest that
MRC1 gene variants may contribute to the development
of sarcoidosis.
The rs691005 located within the 3’-untranslated
region (3’-UTR) of MRC1 showed the strongest associa-
tion (OR 2.53). Although the real functions of this gene
are unclear, variants in the 3’-UTR are known to disrupt
a regulatory binding sequence and alter mRNA expres-
sion [23]. Alternatively, thisv a r i a n tm a yb er e p r e s e n t a -
tive of the region or correlated with a true functional
variant. Thus, our current results provide a basis for
further identification of the causative variants underlying
the relationship between MRC1 gene sequences and
sarcoidosis.
It should be noted that SNPs with two positions were
mapped to MRC1 spanning chr10:17,891,368-17,993,183
(HapMap Data Rel 27) and were referred to by their
MRC1L1 ’rs’numbers (NCBI EntrezSNP database Build
130). Alter et al reported no evidence for a common
Table 3 Allele and genotype frequencies for 9 SNPs in MRC1 among subjects with sarcoidosis and control subjects
SNP ID Locus* Role AA change Allele Controls n (%) Cases n (%) P
† Genotype Controls n (%) Cases n (%) P
‡
rs2477637 12555 intron1 none A 547 (64.5) 213 (58.8) 0.062 AA 180 (42.5) 73 (40.3) 0.016
G 301 (35.5) 149 (41.2) AG 187 (44.1) 67 (37.0)
GG 57 (13.4) 41 (22.7)
rs2253120 13789 exon2 none G 638 (75.2) 253 (69.9) 0.053 GG 250 (59.0) 86 (47.5) 0.016
A 210 (24.8) 109 (30.1) AG 138 (32.5) 81 (44.8)
AA 36 (8.5) 14 (7.7)
rs2477631 17023 intron2 none A 443 (52.2) 191 (52.8) 0.868 AA 120 (28.3) 46 (25.4) 0.296
C 405 (47.8) 171 (47.2) AC 203 (47.9) 99 (54.7)
CC 101 (23.8) 36 (19.9)
rs2477664 24351 exon4 none A 455 (53.7) 191 (52.8) 0.776 AA 131 (30.9) 49 (27.1) 0.412
T 393 (46.3) 171 (47.2) AT 193 (45.5) 93 (51.4)
TT 100 (23.6) 39 (21.5)
rs692527 31598 intron5 none A 474 (55.9) 184 (50.8) 0.105 AA 130 (30.7) 50 (27.6) 0.145
G 374 (44.1) 178 (49.2) AG 214 (50.5) 84 (46.4)
GG 80 (18.9) 47 (26.0)
rs1926736 40240 exon7 Gly/Ser G 443 (52.2) 198 (54.7) 0.433 GG 111 (26.2) 56 (30.9) 0.455
A 405 (47.8) 164 (45.3) AG 221 (52.1) 86 (47.5)
AA 92 (21.7) 39 (21.5)
rs544995 111041 3’-UTR none G 598 (70.5) 254 (70.2) 0.957 GG 200 (47.2) 88 (48.6) 0.526
A 250 (29.5) 108 (29.8) AG 198 (46.7) 78 (43.1)
AA 26 (6.1) 15 (8.3)
rs544995 111065 3’-UTR none G 522 (63.4) 239 (66.0) 0.159 GG 163 (38.4) 75 (41.4) 0.148
A 326 (39.6) 123 (34.0) AG 196 (46.2) 89 (49.2)
AA 65 (15.3) 17 (9.4)
rs691005 111380 3’-UTR none T 576 (67.9) 226 (62.4) 0.064 TT 191 (45.0) 79 (43.6) 0.003
C 272 (32.1) 136 (37.6) TC 194 (45.8) 68 (37.6)
CC 39 (9.2) 34 (18.8)
* Nucleotide numbering starts from the first nucleotide of the transcription start site.
† Allele frequencies of each SNP were compared between sarcoidosis and controls by c2 test (2 × 2).
‡ Overall genotype differeneces were compared between sarcoidosis and controls by c2 test (2 × 3).
Table 4 Odds ratios (OR) and P values for 9 SNPs in
MRC1 among subjects with sarcoidosis and control
subjects
Dominant model Recessive model
OR [95% CI]* P value* OR [95% CI]* P value*
rs2477637 1.04 [0.71-1.52] 0.843 1.76 [1.09-2.84] 0.02
rs2253120 1.62 [1.12-2.36] 0.011 0.83 [0.42-1.65] 0.593
rs2477631 1.08 [0.70-1.64] 0.739 0.79 [0.50-1.24] 0.298
rs2477664 1.18 [0.78-1.78] 0.433 0.87 [0.56-1.36] 0.535
rs692527 1.15 [0.76-1.74] 0.496 1.58 [1.02-2.46] 0.042
rs1926736 0.78 [0.52-1.17] 0.222 0.97 [0.62-1.53] 0.906
rs554995 0.90 [0.62-1.31] 0.588 1.43 [0.70-2.95] 0.326
rs554313 0.83 [0.57-1.21] 0.336 0.65 [0.36-1.18] 0.159
rs691005 1.00 [0.69-1.46] 0.987 2.53 [1.47-4.37] 0.001
* logistic regression model: adjusted by sex and age.
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Page 4 of 6gene duplication event [24]. The authors suggested that
MRC1L is an erroneous annotation caused by the pre-
sence of a sequence gap and the incorrect assignment of
a polymorphic haplotype.
We also reported the association of MRC1 gene poly-
morphism and risk of asthma in two independent ethni-
cally diverse populations [19], suggesting that MRC1
might be involved in the pathogenesis of a number of
chronic inflammatory diseases. Several reports have
shown that genetic variants of genes related to PRRs
such as TLR4 and CD14 are associated with susceptibil-
ity to both diseases [10,11,25-27]. The present study
adds further evidence supporting the involvement of
macrophage PRRs in the development of sarcoidosis as
a chronic inflammatory lung disease.
Of the SNPs examined, three SNPs (rs26777637,
rs2253120 and rs692427) showed tendency for associa-
tion with sarcoidosis (P =0 . 0 2 ,P =0 . 0 1 1 ,P =0 . 0 4 2 ) ,
but this association did not reach significance after the
Bonferroni correction. However, associations of
rs691005 remained significant even after Bonferroni cor-
rection (P = 0.001). In addition, power calculations
based on study subjects of 181 cases and 424 controls,
OR of 2.53 showed a sufficient genetic power (0.81) at
the level of significance of 0.005. As the sample size of
this study is not sufficiently large and is restricted to
Japanese population, the present data should be vali-
dated in larger samples and in other ethnic groups.
Conclusions
This study suggests that the MRC1 gene may represent
an important susceptibility locus for sarcoidosis at chro-
mosome 10p12 and genetic variants in MRC1 may play
significant roles in the pathogenesis of sarcoidosis.
Importantly, the association we observed between
MRC1 polymorphisms and sarcoidosis adds further evi-
dence for the involvement of macrophage PRRs in the
development of a number of chronic inflammatory dis-
eases, including sarcoidosis. However, further studies are
clearly needed to achieve a comprehensive coverage of
genetic variants in and around the MRC1 gene, in order
to identify causal variants conferring susceptibility to an
increased risk of sarcoidosis.
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